- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | MTL Cannabis Corp. Files Third Quarter Results | 1 | CNW | ||
| 24.02. | MTL Cannabis Corp: MTL Cannabis has court OK for acquisition by Canopy | 27 | Stockwatch | ||
| 23.02. | MTL Cannabis Obtains Final Court Approval for Plan of Arrangement with Canopy Growth | 7 | CNW | ||
| 18.02. | MTL Cannabis Corp: MTL Cannabis shareholders approve Canopy deal | 4 | Stockwatch | ||
| MTL CANNABIS Aktie jetzt für 0€ handeln | |||||
| 18.02. | Canopy Growth Announces MTL Cannabis Shareholder Approval of Acquisition | 17 | MarijuanaStocks.com | ||
| 18.02. | MTL Cannabis shareholders approve acquisition by Canopy Growth | 46 | Investing.com | ||
| 18.02. | MTL Cannabis Corp.: MTL Cannabis Announces Shareholder Approval of Arrangement with Canopy Growth | 338 | PR Newswire | PICKERING, Ontario, Feb. 18, 2026 /CNW/ - MTL Cannabis Corp. (CSE: MTLC; OTCQX: MTLNF) ("MTL Cannabis" or the "Company") is pleased to announce that at its special... ► Artikel lesen | |
| 11.02. | MTL Cannabis Corp: MTL Cannabis reminds shareholders of voting deadline | 5 | Stockwatch | ||
| 10.02. | MTL Cannabis Reminds MTL Shareholders to Vote FOR the Arrangement Resolution to Approve the Proposed Plan of Arrangement with Canopy Growth at the Upcoming Special Meeting of MTL Shareholders | 57 | CNW | ||
| 28.01. | MTL Cannabis Corp: MTL Cannabis mails info circular for special meeting | 14 | Stockwatch | ||
| 27.01. | MTL Cannabis Announces Mailing of the Management Information Circular in Connection with its Special Meeting of Shareholders to Approve the Acquisition by Canopy Growth | 52 | CNW | ||
| 15.12.25 | Canopy Growth To Acquire MTL Cannabis | 58 | Benzinga.com | ||
| 15.12.25 | Canopy Growth to acquire MTL Cannabis in $179 million deal | 68 | Investing.com | ||
| 15.12.25 | Canopy Growth signs deal to buy MTL Cannabis in agreement valued at $125M | 47 | BNN Bloomberg | ||
| 15.12.25 | Canopy Growth buys MTL Cannabis for C$125 million, sending shares higher | 49 | Seeking Alpha | ||
| 15.12.25 | Canopy Growth Corporation to Acquire MTL Cannabis Corp.; Transaction Expected to Create Canada's Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand | 432 | Business Wire | This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024
All... ► Artikel lesen | |
| 28.11.25 | MTL Cannabis Corp: MTL Cannabis loses $8.32-million in fiscal Q2 | 3 | Stockwatch | ||
| 28.11.25 | MTL Cannabis Corp. Reports Second Quarter Results with $25.4 Million of Revenue, Strong Gross Margins, and Strengthened Balance Sheet | 2 | CNW | ||
| 19.09.25 | MTL Cannabis Corp: MTL Cannabis closes $2-million brokered offering | 1 | Stockwatch | ||
| 19.09.25 | MTL Cannabis Corp. Announces Closing of $2 Million Brokered LIFE Offering Led by Centurion One Capital | 1 | CNW |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 30,960 | -3,76 % | Hims & Hers nach Preisattacke auf Novo Nordisk mit Zahlen: Aktie rauscht erneut in den Keller | Die US-amerikanische Telemedizin-Plattform Hims & Hers hat am Montag nach Börsenschluss die Zahlen für das vierte Quartal respektive Gesamtjahr 2025 vorgelegt. Überschattet werden die Ergebnisse und... ► Artikel lesen | |
| AURORA CANNABIS | 3,105 | -2,66 % | Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom? | ||
| CANOPY GROWTH | 0,896 | -3,55 % | Is It Time to Dump Your Shares of Canopy Growth?? | ||
| TILRAY BRANDS | 6,320 | -2,92 % | MDMA-Herausforderer Bioxyne punktet mit 112% Umsatzplus. Und was macht Tilray? | ||
| VERTEX PHARMACEUTICALS | 415,50 | -0,10 % | Vertex Pharmaceuticals Inc. Reports Rise In Q4 Bottom Line | CAMBRIDGE (MASSACHUSETTS) (dpa-AFX) - Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its fourth quarter that Increases, from last yearThe company's earnings came in at $1.191 billion... ► Artikel lesen | |
| INNOCAN PHARMA | 4,200 | +0,96 % | Innocan Pharma Corporation: FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time | HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"),... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,240 | -0,62 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| SYNBIOTIC | 2,315 | -0,86 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | -33,33 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,180 | +3,51 % | Organigram Global Inc: Organigram launches Edison, Boxhot in Australia | ||
| GREEN THUMB INDUSTRIES | 5,450 | +0,55 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2025 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,285 | -0,70 % | 1CM Inc.: SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased... ► Artikel lesen | |
| CRESCO LABS | 0,800 | +1,01 % | Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,076 | +51,20 % | JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. And Pioneer Garage Limited |
MTL CANNABIS CORP gehört der Branche Pharma an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,322 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MTL CANNABIS CORP finden Sie auf Wallstreet Online.